Townsend Christopher G 4

4 · METLIFE INC · Filed Nov 8, 2017

Form 4

Period: 2017-11-06

President, Asia Region

Transactions

Exercise/Conversion
Common Stock
2017-11-06$34.33/sh+13,106$449,929→ 13,106 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-06−17,425→ 8,713 total
Exercise: $45.91Exp: 2025-02-23→ Common Stock (17,425 underlying)
Exercise/Conversion
Common Stock
2017-11-06$45.15/sh+25,181$1,136,922→ 25,181 total
Exercise/Conversion
Common Stock
2017-11-06$45.91/sh+17,425$799,982→ 17,425 total
Sale
Common Stock
2017-11-06$54.20/sh−13,106$710,345→ 0 total
Sale
Common Stock
2017-11-06$54.34/sh−25,181$1,368,411→ 0 total
Sale
Common Stock
2017-11-06$54.29/sh−17,425$945,986→ 0 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-06−25,181→ 0 total
Exercise: $45.15Exp: 2024-02-24→ Common Stock (25,181 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-11-06−13,106→ 26,216 total
Exercise: $34.33Exp: 2026-02-22→ Common Stock (13,106 underlying)

Footnotes (7)

[F1]The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.
[F2]The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive.
[F3]The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive.
[F4]The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive.
[F5]The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017.
[F6]The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018.
[F7]The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019.

Documents

1 file